Lorem ipsum dolor sit amet, consectetur adipiscing elit
In 2016, Yasser Iturria-Medina, Ph.D., and his post-doctoral supervisor at the time, Alan Evans, Ph.D., published findings that quietly helped shift how scientists think about Alzheimer’s disease. Today, that work has informed several therapeutic patents and opened the door to a distinct class of drug targets currently being tested on patients around the world.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Announcements
2025 Rising Stars Trainee Award Recipients
Brain Canada is proud to announce the 2025 Rising Star Trainee Award recipients, a new cohort of trainees (master’s students, PhD students and postdoctoral fellows) whose work is advancing our understanding of brain health across Canada.
Shifting paradigms, informing solutions in Alzheimer’s disease
In 2016, Yasser Iturria-Medina, Ph.D., and his post-doctoral supervisor at the time, Alan Evans, Ph.D., published findings that quietly helped shift how scientists think about Alzheimer’s disease. Today, that work has informed several therapeutic patents and opened the door to a distinct class of drug targets currently being tested on patients around the world.
Screens are changing young brains. Canada needs a plan
Dr. Emma Duerden is an associate professor and Canada Research Chair in neuroscience and learning disorders – applied psychology at Western University. Dr. Franco Vaccarino is professor emeritus at the University of Guelph and former president and vice chancellor. Alison Palmer is the evaluation and special projects lead at Brain Canada Foundation.
As part of our mission to fund bold brain research, Brain Canada has, together with its donors and partners, supported dozens of large-scale research projects and platforms to develop and apply cutting-edge AI approaches to advance our understanding of the brain and identify solutions for brain diseases and disorders.
Canada has always invested in brain science, even during fiscal challenges. While others pursue AI dominance through speed and scale, we could lead by putting human cognition at the centre.
On Sunday, October 26th, Riverdale Farm in Toronto came alive with laughter, energy, and purpose as dozens gathered for the first-ever Functional Phil Community Walk.
Dr. Sylvia Villeneuve is accelerating research on Alzheimer’s across the globe. By sharing comprehensive data from preclinical Alzheimer’s disease (AD) patients, the Canadian Alzheimer’s Prevention Data Repository and Sharing (CAP) platform, headed by Villeneuve, is bolstering research studies across hundreds of research groups. Already, the platform is hosting data that has been used to uncover significant findings, enabling a greater understanding of the disease in its early stages – before symptoms appear.
